Skip to content
MedsAcross

Fixed-dose combination

Neomycin and Polymyxin b

Also known as neomycin sulfate, polymyxin b sulfate
Available on requestCold chain
Presentations
1
Brands
0
Manufacturers
0
Available from stock
0

Neomycin and Polymyxin b is a fixed-dose combination of an aminoglycoside antibacterial and a polymyxin-class antibacterial. It is available as irrigation solution. MedsAcross supplies Neomycin and Polymyxin b for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Aminoglycoside Antibacterial, Polymyxin-class Antibacterial
US FDA first approval
12 March 1974
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Irrigation
Dosage forms
Irrigation solution
Fixed-dose combination of
Neomycin, Polymyxin b

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

Neomycin and Polymyxin B Sulfates Solution for Irrigation is indicated for short-term use (up to 10 days) as a continuous irrigant or rinse in the urinary bladder of abacteriuric patients to help prevent bacteriuria and gram-negative rod septicemia associated with the use of indwelling catheters. Since organisms gain entrance to the bladder by way of, through, and around the catheter, significant bacteriuria is induced by bacterial multiplication in the bladder urine, in the mucoid film often present between catheter and urethra, and in other sites. Urinary tract infection may result from the repeated presence in the urine of large numbers of pathogenic bacteria. The use of closed systems with indwelling catheters has been shown to reduce the risk of infection.

Source: US FDA prescribing information

Dosing overview

This preparation is specifically designed for use with “three-way catheters or with other catheter systems permitting continuous irrigation of the urinary bladder. The usual irrigation dose is 1 mL of Neomycin and Polymyxin B Sulfates Solution for Irrigation a day for up to 10 days. Using strict aseptic techniques, 1 mL of Neomycin and Polymyxin B Sulfates Solution for Irrigation should be added to a 1,000-mL container of isotonic saline solution. This container should then be connected to the inflow lumen of the “three-way” catheter which has been inserted with full aseptic precautions, use of a sterile lubricant is recommended during insertion of the catheter. The outflow lumen should be connected, via a sterile disposable plastic tube, to a disposable plastic collection bag.

Source: US FDA prescribing information

Contraindications

Hypersensitivity to neomycin, the polymyxins, or any ingredient in the solution is a contraindication to its use. A history of hypersensitivity or serious toxic reaction to an aminoglycoside may also contraindicate the use of any other aminoglycoside because of the known cross-sensitivity of patients to drugs of this class.

Source: US FDA prescribing information

Warnings and precautions

PROPHYLACTIC BLADDER CARE WITH NEOMYCIN AND POLYMYXIN B SULFATES SOLUTION FOR IRRIGATION SHOULD NOT BE GIVEN WHERE THERE IS A POSSIBILITY OF SYSTEMIC ABSORPTION. NEOMYCIN AND POLYMYXIN B SULFATES SOLUTION SHOULD NOT BE USED FOR IRRIGATION OTHER THAN FOR THE URINARY BLADDER. Systemic absorption after topical application of neomycin to open wounds, burns, and granulating surfaces is significant and serum concentrations comparable to and often higher than those attained following oral and parenteral therapy have been reported. Absorption of neomycin from the denuded bladder surface has been reported.

Source: US FDA prescribing information

Side effects

Neomycin occasionally causes skin sensitization when applied topically, however, topical application to mucus membranes rarely results in local or systemic hypersensitivity reactions. Irritation of the urinary bladder mucosa has been reported. Signs of ototoxicity and nephrotoxicity have been reported following parenteral use of drugs and following the oral and topical use of neomycin.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

1 presentations of Neomycin and Polymyxin b, sorted by availability.

MedicineActive ingredientManufacturerRegisterAvailability
Neomycin and Polymyxin b 40 mg/200000 units per mL irrigation solutionIrrigation Cold chainGeneric nameNeomycin and Polymyxin b—US FDAAvailable on request

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 12 March 1974Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Neomycin and Polymyxin b available for export from India?

Yes, on request. MedsAcross lists 1 presentations of Neomycin and Polymyxin b and sources them for licensed hospitals, importers and physicians against valid import documents.

Is Neomycin and Polymyxin b approved by the US FDA?

Yes. The US FDA first approved Neomycin and Polymyxin b on 12 March 1974, according to Drugs@FDA.

Does Neomycin and Polymyxin b need cold chain shipping?

At least one listed presentation of Neomycin and Polymyxin b must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.

References

  1. Neomycin and Polymyxin B Sulfates prescribing information (XGen Pharmaceuticals DJB). U.S. National Library of Medicine, DailyMed. Retrieved 18 March 2026

Request Neomycin and Polymyxin b for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.